Evaluation of the efficacy, safety and tolerability of tacrolimus ointment in Indian patients of moderate to severe atopic dermatitis: A multicentric, open label, phase III study

Indian Journal of Dermatology, Venereology and Leprology

Volumn 69, Issue 6, 2003, Pages 396-400

  Saple, D G ^a   Torsekar, R G ^b   Pawanarkar, Vikas ^c   Wali, Vijaykumar ^d   Ravichandran, G ^e   Dhanalakshmi, U R ^f   Dongre, Neelesh ^g   Ballary, Chetna ^g   Desai, Anish ^g  

^a GT Hospital Mumbai   (India)

^b GANDHI MEDICAL COLLEGE   (India)

^c Pramila Hospital   (India)

^d M R MEDICAL COLLEGE   (India)

^e Zubeda Hospital   (India)

^f B R Hospital   (India)

^g Glenmark Pharmaceuticals Limited   (India)

Author keywords

Atopic dermatitis; Efficacy; Safety; Tacrolimus

Indexed keywords

IMMUNOMODULATING AGENT; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; BURNING SENSATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FOLLICULITIS; FOLLOW UP; HEADACHE; HUMAN; INDIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED ECZEMA AREA SENSITIVITY INDEX; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; PRURITUS; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 33646471068     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rudikoff D. Atopic dermatitis. Lancet 1998;351:1715-21.
2. Leung DM. Pathogenesis of atopic dermatitis. J Allergy Clin Immunology 1998;104:599-607.
3. Cheer SM. Tacrolimus ointment: A review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2001;2:389-406.
4. Rajka G, Langeland T. Grading of severity of atopic dermatitis. Acta Derm Venerol Suppl (Stockh) 1989;144:13-4.
5. Hanifin JM. Biochemical and Immunological mechanisms in atopic dermatitis: new targets for emerging therapies. J Am Acad Dermat 1999;41:72-7.
6. Hanifin JM. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients. Part I: Efficacy. J Am Acad Dermatol 2001;44:528-38.
7. Paller A. A 12 week study of Tacrolimus ointment for the trestment of atopic dermatitis in paediatric patients J Am Acad of Dermatol 2001;44:547-57.
8. Ruzicka T. A short term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus multicentric atopic dermatitis study group. New Eng J Med 1997;377:816-21.
9. Boguniewicz M. A randomized vehicle controlled trial of Tacrolimus ointment for the treatment of atopic dermatitis in children. J Allergy Clin Immunol 1998;102:637-44.
10. Reitamo S. Safety and efficacy of 1 yr of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000;136:999-1006.
11. Soter NA. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients. Part II : Safety. J Am Acad Dermatol 2001;44:539-46.
12. Kang S. Long term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44:558-64.
13. Remitz A. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 2001;107:196-7.
14. Reitamo S. Tacrolimus ointment does not affect collagen synthesis: results of a single center randomized trial. J Invest Dermatol 1998;111:396-8.
15. Koo JYM. Tacrolimus ointment safe in extended treatment study. American Academy of Dermatology, 61st Annual Meeting: 2003. Abstract p. 22.
16. Alaiti S. Tacrolimus ointment for atopic dermatitis: A phase I study in adults and children. J Am Acad Dermatol 1998;38:69-76.
17. Makagewa H. Comparative study of tacrolimus ointment Vs alclometasone diproprionate ointment in atopic dermatitis (Face and Neck lesions). J Invest Dermat 1998;110:683.
18. Reitamo S. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-46.
19. Drake L. The impact of tacrolimus ointment on health related quality of life of adult and paediatric patients with atopic dermatitis. J Am Acad Dermatol 2001;44:S65-72.
20. Hanifin J. American Academy of Allergy, Asthma, and Immunology, 60th annual meeting. Abstract 2003. p. 244.
21. Cather JC, Abramovits W, Menter A. Cyclosporine and Tacrolimus in dermatology. Dermatol Clin 2001;19;119-37.